News on government policy and legislation impacting life science and diagnostics.
The five-year initiative aims to collect and disseminate genomic data on 1 million people with Alzheimer's disease or who are at risk for the condition.
The groups have written draft recommendations and are now asking for public comment from pathologists and other stakeholders.
The bipartisan bill is backed by more than 250 organizations, but ACMG remains opposed, arguing that ordering tests is part of the practice of medicine.
The president's latest budget request marks the fourth time he has sought to reduce funding to the National Institutes of Health.
The European Patent Office appeals board upheld the decision made by the EPO after its initial review in 2018.
The New York Times looks at companies using genomic tools to try to quickly identify the cause of patients' infections.
The White House has asked for $2.5 billion in funding to address the COVID-19 outbreak, according to the Associated Press.
A resignation at the Marine Biological Laboratory highlights that institutions are unsure of how to handle researchers previously found to have violated codes of conduct, Nature News says.
In PNAS this week: immune responses that affect heart transplant rejection risk, gene variants associated with thiopurine toxicity, and more.